Bulletin
Investor Alert

Verve Therapeutics Inc.

NAS: VERV

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Verve Therapeutics Inc.

After Hours

VERV
/zigman2/quotes/227446048/composite

$

22.50

Change

+0.08 +0.36%

Volume

Volume 9,860

Jan 27, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/227446048/composite

Previous close

$ 22.01

$ 22.42

Change

+0.41 +1.86%

Day low

Day high

$21.78

$22.92

Open
Open: 21.78

52 week low

52 week high

$10.70

$43.00

Open

Market cap

$1.38B

Average volume

825,559

P/E ratio

N/A

Rev. per Employee

$8,221

EPS

-2.90

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/verv

MarketWatch News on VERV

  1. What’s Next for the Healthcare Industry, and How to Invest

    8:47 a.m. Sept. 25, 2022

    - Barron's Online

  2. Verve Therapeutics stock upgraded to buy from hold at Stifel

    5:48 a.m. Aug. 25, 2022

    - Emily Bary

  3. Verve Therapeutics price target increased to $56 from $32 at Stifel

    5:49 a.m. Aug. 25, 2022

    - Emily Bary

  4. 25 Stocks That Could Rise on a Short Squeeze

    8:30 p.m. July 22, 2022

    - Barron's Online

  7. Verve Therapeutics started at outperform with $48 stock price target at BMO Capital

    11:26 a.m. June 17, 2022

    - Tomi Kilgore

  8. Verve Therapeutics reiterated as hold with $58 stock price target at Stifel

    6:59 a.m. Dec. 23, 2021

    - Ciara Linnane

  9. Gene Editor Verve Unveils Second Way to Lower Cholesterol

    4:19 a.m. Nov. 12, 2021

    - Barron's Online

  10. Beam Gets FDA Nod for First Gene-Editing Trial

    8:10 a.m. Nov. 9, 2021

    - Barron's Online

  11. Gene Therapy Is a Huge Opportunity. It Pays to be Patient.

    8:46 p.m. Nov. 5, 2021

    - Barron's Online

  12. Verve Therapeutics started at hold with $58 stock price target at Stifel Nicolaus

    7:00 a.m. Sept. 24, 2021

    - Tomi Kilgore

  13. Verve started at neutral with $50 stock price target at J.P. Morgan

    6:20 a.m. July 12, 2021

    - Tomi Kilgore

  15. Verve Therapeutics shares soar 68% in trading debut

    11:47 a.m. June 17, 2021

    - Ciara Linnane

/news/nonmarketwatch/company/us/verv

Other News on VERV

  1. Verve Therapeutics: Exciting Science And A Rich Valuation

    3:39 a.m. Nov. 10, 2022

    - Seeking Alpha

  2. Verve Therapeutics (VERV) Investor Presentation - Slideshow

    11:29 p.m. Nov. 9, 2022

    - Seeking Alpha

  5. ACMR, ARQQ and NXTC among mid-day movers

    1:16 p.m. Nov. 7, 2022

    - Seeking Alpha

  8. 10-Q: VERVE THERAPEUTICS, INC.

    7:39 a.m. Nov. 7, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  10. Prime Medicine: CRISPR 3.0 Company

    6:52 p.m. Oct. 24, 2022

    - Seeking Alpha

  15. Verve Therapeutics: Cathie Wood Adds To ARKK

    3:57 a.m. Sept. 20, 2022

    - Seeking Alpha

  16. Crispr Gene-Editing Drugs Show Promise in Preliminary Study

    1:33 a.m. Sept. 17, 2022

    - The Wall Street Journal Interactive Edition

  17. Intellia falls as analysts react to CRISPR readouts

    11:16 a.m. Sept. 16, 2022

    - Seeking Alpha

  18. Beam Therapeutics: Now Is Not The Right Time To Own

    5:38 p.m. Sept. 15, 2022

    - Seeking Alpha

  19. Why Verve Therapeutics Stock Crushed It This Week

    11:30 a.m. Aug. 27, 2022

    - Motley Fool

  21. Loading more headlines...
/news/pressrelease/company/us/verv

Press Releases on VERV

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.